Found 32 matching trials
A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea N/A The purpose of this study is to monitor the long-term safety of participant...
Show More Location
Chonnam National University Hwasun Hospital
Learn More & Join Trial
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma PHASE1 This is a Phase 1 study to evaluate the safety of CB-011 (the study treatme...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation PHASE3 The purpose of this study is to compare the efficacy, safety, and tolerabil...
Show More Status
Active Not Recruiting
Location
Local Institution - 0131
Learn More & Join Trial
Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy N/A The goal of this observational study is to learn about vaccine immunity in ...
Show More Location
University Hospital Bern
Learn More & Join Trial
Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) PHASE3 This is a multicenter, randomized, open-label, Phase 3 study comparing the ...
Show More Location
Local Institution - 109
Learn More & Join Trial
Elranatamab in R/R Multiple Myeloma PHASE2 This research is being done to see if the study drug, elranatamab, reduces ...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple Myeloma PHASE1 This phase I trial studies the safety, side effects, best dose and effectiv...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Nivolumab in Multiple Myeloma Patients After Idecabtagene Vicleucel PHASE2 This study is designed to evaluate if treatment with adjuvant nivolumab imp...
Show More Status
Active Not Recruiting
Location
Levine Cancer Institute
Learn More & Join Trial
Anti-BCMA CAR T-Cell Therapy for R/R ITP PHASE2 This is a prospective, single-center, open-label, single-arm study, to eval...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy N/A The purpose of this transgene assay testing service is to evaluate tumor sa...
Show More Location
Local Institution - 0016
Learn More & Join Trial